Tumor markers carcinoembryonic antigen, tissue polypeptide antigen, and carbohydrate antigen 19/9 in liver diseases | Zendy

Putzki H. | Zendy; Ledwoch J. | Zendy; Student A. | Zendy; Jablonski M. | Zendy; Heymann H. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Tumor markers carcinoembryonic antigen, tissue polypeptide antigen, and carbohydrate antigen 19/9 in liver diseases

Author(s) -

Putzki H.,

Ledwoch J.,

Student A.,

Jablonski M.,

Heymann H.

Publication year - 1988

Publication title -

journal of surgical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.201

H-Index - 111

eISSN - 1096-9098

pISSN - 0022-4790

DOI - 10.1002/jso.2930370214

Subject(s) - carcinoembryonic antigen , antigen , medicine , liver tissue , pathology , immunology , cancer

The tumor markers carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA), and carbohydrate antigen 19/9 (CA19/9) have been compared with regard to their sensitivity to liver diseases. All three markers have been found to be sensitive to liver diseases, but to a different degree: TPA rises the most; CEA the least. The sensitivities of TPA and CA19/9 are higher in a group of liver diseases than, for comparison, in a group of colorectal carcinomas.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research